|
Mutation Information
|
Mutation Site
|
M204I |
|
Mutation Type
|
Amino acid level |
|
Gene/Protein/Region Type
|
RT |
|
Genotype/Subtype
|
A1 |
|
Relevant Drug
|
lamivudine (LAM) |
|
Country
|
South Africa |
Literature Information
|
PubMed PMID
|
33357228
|
|
Disease
|
HBV-HCV-HIV coinfection
|
|
Published Year
|
2020 |
|
Journal
|
BMC pediatrics |
|
Title
|
Viral hepatitis B and C in HIV-exposed South African infants. |
|
Author
|
Tamandjou Tchuem C,Cotton MF,Nel E,Tedder R,Preiser W,Violari A,Bobat R,Hovind L,Aaron L,Montepiedra G,Mitchell C,Andersson MI |
|
Evidence
|
The rtM204I mutation associated with lamivudine resistance was identified in one infant, a second infant harboured the double A1762T/G1764A BCP mutation.
|
|
|
HBV Mutation Detail Information